Finally, angiotensin-converting enzyme (ACE) inhibitors were considered to address his proteinuria but were ultimately reserved until the KDIGO 2024 CKD guidelines were met: moderate-to-severe albuminuria, urine albumin-to-creatinine ratio (ACR) > 30 mg/mmol, or hypertension [9]. This evidence concerns the gene ACE and chronic kidney disease.